Network

Networks

Network News

18 Dec 2020

Nature’s 10: Institut Pasteur de Montevideo recognized for its response to COVID-19

In the 2020 edition of its annual listicle of 10 people who helped shape science, the scientific journal Nature highlighted the work by Gonzalo Moratorio, head of laboratory at the Institut Pasteur de Montevideo, in the successful response to COVID-19 in Uruguay. 
 
Uruguay continues to record one of the world’s lowest death tolls — only 87 people by 10 December — and part of this impressive response is due to Gonzalo Moratorio and his colleagues, who designed a coronavirus test and a national programme for administering it that has helped to keep COVID-19 cases at bay as outbreaks have swept through Latin America. 
 
 
 

24 Nov 2020

Congratulations to Sophie Valkenburg and Roman Thibeaux for receiving the Pasteur Network Talent Award 2020!

The Pasteur Network Talent Award, issued by the Institut Pasteur each year, recognizes the  achievements of two talented scientists from the Pasteur International Network who have demonstrated strong scientific or leadership potential either in public health or fundamental research, and who wish to pursue and strengthening their research within the Network.

For the 2020 edition, Dr Sophie Valkenburg at HKU-Pasteur Research Pole has received the Award for her project regarding SARS-CoV-2 second generation vaccines and their mechanism of protection. Stemming from the work achieved with her research team on immune responses to influenza viruses and SARS-CoV-2 patient serology tests, this project will focus on vaccination. Defining immune correlates from recovered patients helps to direct vaccine programs. This can determine vaccine design and expectations for protection of the individual from infection or disease and transmission.

She received this award along with Roman Thibeaux at Institut Pasteur Nouvelle-Calédonie for his project aiming at unravelling the cyclic-di-GMP network regulating biofilm formation and virulence in the zoonotic pathogen Leptospira interrogans. He is currently involved in the the SpIRAL project linked to the French National Research Agency (ANR), aiming at determining the preferred hydro-telluric habitat of virulent leptospires, not only to better understand leptospirosis epidemiology, but also to infer risk management approaches and interventions for a better control of the disease in humans. This new project aims at developing further new and existing strategic partnerships focused on one of the Priority disease of the Institut Pasteur International Network strategy.

Successful candidates have presented their work on the occasion of the Pasteur Network Talent Award Ceremony, and have received a reward to pursue their project (remittance is subject to the receipt of all necessary documents for the wire transfer- in euros).

Once again congratulations to both Sophie and Roman for this reward!

 

24 Nov 2020

Work In Progress at Science Park!

The Institut Pasteur and HKU are joining forces to establish the Center for Immunology & Infection (C2I) at the Hong Kong Science and Technology Parks.
 
This new translational program, which is distinct from HKU-Pasteur, was announced during the ceremony of the 20th Anniversary of HKU-Pasteur on October 21, 2020.
 
This major initiative is funded by Health@InnoHK with a goal to boost innovative strategies to identify and contain emerging infectious diseases and enhance Hong Kong and the Greater Bay Area position as a global hub of knowledge-based economy.
 
We are very excited to share with you in images the work in progress at C2I.
 
See you in 2021 for the grand opening! 
 
In the meantime, stay tuned on HKU-Pasteur?s website for more news, updates and career opportunities at C2I. 
 
 
 

18 Sep 2020

Institut Pasteur International Network In Asia Pacific’s Involvement In The Fight Against Covid-19

Since the beginning of the Covid-19 outbreak – caused by a newly identified coronavirus SARS-CoV-2 – which emerged at the end of 2019 in Wuhan, China, the Institut Pasteur International Network in Asia Pacific have been at the forefront of the research conducted on the topic. 
 
In addition of our work on coronaviruses here at HKU-Pasteur Research Pole, the Institut Pasteur International Network in Asia Pacific has been deeply active since the beginning of the pandemic on testing, detection tools, immunity, as well as vaccine and treatment research.
 
Highlights of selected studies by the IPIN in Asia Pacific
 
Institut Pasteur du Cambodge – Besides the conduction of studies on the surveillance of Covid-19 in Cambodia and in Lao People's Democratic Republic, the Institut Pasteur du Cambodge is part of the Institut Pasteur Task Force on Covid-19 in the project “Covid-19 Serosurvey”. This project is aiming at developing simple serological screening tools and a targeted serosurvey of at-risk individuals. 
 
Institut Pasteur Korea – On July 6 2020, the Institut Pasteur Korea has launched a joint research and clinical trial for development of COVID-19 treatment, in collaboration with Chong Kun Dang Pharm, and the Korea Institute of Radiological & Medical Sciences. A clinical trial, using “Nafamostat” as a treatment against Covid-19, has been launched in Senegal, through a collaboration between Institut Pasteur Korea, Institut Pasteur de Dakar and the French Ministry for Europe and Foreign Affairs. On May-June 2020, the Institute has conducted a major study on the identification of antiviral drug candidates against SARS-CoV-2, using FDA-approved drugs, further investigated in August 2020.
 
Institut Pasteur du Laos – As part of the Institut Pasteur Covid-19 Task Force, the Institut Pasteur du Laos is monitoring the origins and transmission of SARS-CoV-2 in Laos and Vietnam. The aim of this project, entitled “SPILLOVER-CORONA”, is to search for SARS-like viruses and detect antibodies invertebrates. 
 
Institut Pasteur de Nouvelle-Calédonie – The Institut Pasteur de Nouvelle-Calédonie is involved in the “EPICOVID Project”, in collaboration with the Institut Pasteur de la Guyane and the Institut Pasteur de la Guadeloupe, as part of the Institut Pasteur Covid-19 Task Force. This project investigates on SARS household transmission in French overseas territories. 
 
Institut Pasteur in Ho Chi Minh City – The Institut Pasteur in Ho Chi Minh City has conducted a significant study on the clinical features and the genome sequence of the SARS-CoV-2 through an investigation from the first two patients in Vietnam. 
 
Institut Pasteur of Shanghai – The Institut Pasteur of Shanghai has launched a large number of decisive studies on SARS-CoV-2 and Covid-19, notably on the evolution of the virus and its characteristics, as well as on the development of a vaccine. Along with several studies conducted on the immune response to the Covid-19 infection, the institute is also part of the Institut Pasteur Covid-19 Task Force within the “NABCOV project” on the identification and isolation of potent human neutralizing antibodies against SARS-CoV-2. 
 
National Institute of Hygiene and Epidemiology (NIHE) – The NIHE in Hanoi, Vietnam, has led several significant studies on Covid-19, with for instance analysis of the first 100 days of SARS-CoV-2 control in Vietnam, or an identification of the factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam. 
 

03 Aug 2020

Need For Sustainable Biobanking Networks For COVID-19 And Other Diseases Of Epidemic Potential

Doctor Amadou Sall, director of the WHO Collaborating Center for arboviruses and viral haemorrhagic fevers, Institut Pasteur de Dakar, Senegal, co-signed a publication in The Lancet Infectious Diseases presenting a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. 
 
Summary:
Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. 
 
We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. 
 
The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential. 
 

21 Jul 2020

Institut Pasteur And HKUMed Working Together On A New Approach For Malaria Diagnosis

Institut Pasteur, Paris, and the LKS Faculty of Medicine of The University of Hong Kong (HKUMed) published in Proceedings of the National Academy of Sciences of the United States of America (PNAS) the results of their collaboration to develop a new approach for Malaria Diagnosis.
 
 
They have demonstrated that evolved specific non-biological molecules could target a malaria biomarker. They are able to carry tasks that normal biological molecules are not able to do and can for example be used to determine the type of malaria infecting a patient. 
 
 
Professor Julian Tanner, Professor and Associate Director (Teaching & Learning) of the School of Biomedical Sciences, Assistant Dean (Biomedical Sciences Curriculum), HKUMed (right); with his research team members, Dr Andrew Kinghorn (1st from left) and Mr Young Lo (2nd from left). Photo: HKUMed

 1 2 3 >  Last »